Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Novo Nordisk · Phase 3 · Recruiting · Enrollment 2500

NCT07564414

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Cagrisema - dose level 1n/rn/rn/rn/r
Cagrisema - dose level 2n/rn/rn/rn/r
Semaglutiden/rn/rn/rn/r

Not shown

  • Cagrisema - dose level 1: endpoint not reported
  • Cagrisema - dose level 2: endpoint not reported
  • Semaglutide: endpoint not reported